Related Experiment Video
Updated: Jul 7, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
[Modification of perioperative drug therapy in cardiovascular, pulmonary or metabolic disease]
Andreas Redel1, Ulrich Schwemmer
1Klinik und Poliklinik für Anästhesiologie, Universitätsklinikum Würzburg. Redel_A@klinik.uni-wuerzburg.de
Abstract:
Almost 50 % of all patients that are evaluated preoperatively by an anesthesiologist are receiving concurrent medication. Many of the prescribed drugs can be omitted during the perioperative period. However, perioperative cessation of certain drug therapies may cause decompensation of primarily compensated diseases. After reading this CME article, the reader should be able to decide whether any cardiovascular, pulmonary or antidiabetic drug therapy should be continued or ceased during the perioperative period, respectively.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Coronary Artery Disease V: Interprofessional Care
Heart Failure VI: Adjunct Therapies